A single centre phase I trial of APG 101 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 May 2009
At a glance
- Drugs Asunercept (Primary)
- Indications Glioblastoma; Graft-versus-host disease; Myelodysplastic syndromes; Myocardial infarction; Solid tumours; Stroke
- Focus Adverse reactions
- Sponsors Apogenix
- 13 May 2009 New trial record.
- 13 May 2009 All endpoints have been met.